Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities.
Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development
Deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development. It can help ensure the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
How Health Systems Can Thrive in Navigating the Specialty Pharmacy Landscape
Specialty pharmacies must meet complex requirements, introducing administrative requirements that can be challenging for health systems to manage internally. Here some strategies that can be employed.
Evolving Capacity to Meet Advanced Biologics Therapies
Creating adequate capacity for any therapeutic can be challenging, and the specialized technologies for manufacturing complex biologics require flexibility and agility in production processes. Here's how contract development and manufacturing organizations (CDMOs) ensure that biopharmaceutical companies have a partner with the speed, flexibility, and expertise necessary for successful drug development and manufacturing.
Buprenorphine Access Still Lags, Even After Major Federal Policy Changes
While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose.
A Bright Future for AI in Pharma
The future will see more pharma companies leveraging AI to improve diversity and inclusion, especially in trials that are diverse by design, as well as the odds of finding patients who fit an acceptable set of inclusion/exclusion criteria to accelerate clinical trial timelines.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
The Future of Drug Discovery is 3D
Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes.
Prioritizing Care That Cures – Fighting the Epidemic With Opioid Treatment Programs
Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth.
Four AI Disruptions in 2025 That Will Reshape Pharma and Healthcare
The future of healthcare will be one where technology doesn't just serve the industry but genuinely improves the lives of individuals, transforming how we interact with medical data, healthcare providers, and our personal well-being.
Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
As the pharmaceutical landscape evolves, small-molecule CDMOs will be essential in balancing supply and demand, driving innovation, and improving patient outcomes. They must continue embracing innovation and strategic agility to survive and thrive in this complex environment.
The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech
This is not just about the science — it is about the leadership that enables it to reach the people who need it most. With the right leadership and a commitment to bold, thoughtful action, the biotech industry is poised to deliver breakthroughs that will transform lives.
Navigating 2025: Three Key Trends Shaping the Future of Pharma
Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.
Precision Medicine: Becoming More Real With AI?
With technology advancements specifically in the field of AI, there is a clear line of sight in making it mainstream. Here are some of the ways AI is helping to accelerate the adoption of PM.
Navigating Virtual Prescribing Policy Changes in 2025
Through collaboration between regulators and healthcare stakeholders, telehealth prescribing can continue to expand treatment access while maintaining proven safety standards.